SCHEMBL9869020

SCHEMBL9869020

Cn1cc([S+](C)[O-])c(=O)c2ccc(OCC(F)(F)F)cc21

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
CYP2C9 P11712 2/20 0.36
HTR6 P50406 1/20 0.36
CYP1A2 P05177 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MAOB P27338 1/20 0.34
CYP17A1 P05093 1/20 0.33
CYP2C19 P33261 1/20 0.33
SCN9A Q15858 3/20 0.33
SCN5A Q14524 1/20 0.33
RAB9A P51151 1/20 0.32
POLB P06746 1/20 0.32
GPR3 P46089 1/20 0.32
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867248 0.85 MAT2A (0.39) ALDH1A1HTR6KDM4ESCN9ASCN5A
SCHEMBL11393569 0.83 PSEN1 (0.37) ALDH1A1RAB9APOLBMEN1KMT2A
SCHEMBL11401796 0.81 ALDH1A1 (0.52) ALDH1A1HTR6KDM4EMAPK1HTT
SCHEMBL9796294 0.81 ALDH1A1 (0.40) ALDH1A1CYP2C9HTR6CYP1A2KDM4E
SCHEMBL7322441 0.80 KIF11 (0.41) SCN9ASCN5A
SCHEMBL9868894 0.80 ALDH1A1 (0.36) ALDH1A1RAB9APOLBMEN1HPGD
SCHEMBL9796302 0.76 SCN9A (0.37) ALDH1A1CYP2C9HTR6CYP1A2KDM4E
Flosequinan SCHEMBL122877 0.76 ATM (0.47) ALDH1A1KDM4ESCN9AMEN1KMT2A
Flosequinan SCHEMBL5442796 0.76 ATM (0.47) ALDH1A1KDM4ESCN9AMEN1KMT2A
Flosequinan SCHEMBL5441172 0.76 ATM (0.47) ALDH1A1KDM4ESCN9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991002724-A1 THERAPEUTIC AGENTS THE BOOTS COMPANY PLC (GB) 1991-03-07 WO disclosed